Pulmatrix cites stockholder nod, S-4 effectiveness in Eos SENOLYTIX merger updateNov 17Quarterly updatePulmatrix, Inc.
AbbVie posts updates on three early-stage trials: obesity, drug interaction, glabellar linesNov 6Weekly roundup, 5 itemsABBV-295AbbVieUpdated
AstraZeneca completes AZD4144-itraconazole PK study; posts five trial records this weekNov 6Weekly roundup, 12 itemsanifrolumab-fniaAstraZenecaUpdated
Lilly posts two DC-806 Phase 1 DDI results; registers three new Phase 3 trialsOct 22Weekly roundup, 11 itemscetuximabdulaglutide
Boehringer Ingelheim registers five new trials, spanning oncology, obesity, and ILD screeningOct 2Weekly roundup, 7 itemsBoehringer IngelheimempagliflozinUpdated
AbbVie registers Phase 1 trial comparing upadacitinib, tofacitinib, baricitinib in healthy adultsSep 30Weekly roundup, 4 itemsABBV-722AbbVie
Merck posts two Phase 3 trials, sotatercept in HFpEF and sac-TMT in bladder cancerSep 24Weekly roundup, 4 itemsMerck & Co., Inc.sotatercept-csrk
Amneal's itraconazole ANDA gets labeling supplement approved by FDASep 14Regulatory decisionAmneal Pharmaceuticals, LLCitraconazole
Novartis-linked melanoma trial posts results; new ITP preference survey and LASIK study activeAug 27Weekly roundup, 4 itemsdabrafenibitraconazole
Boehringer adds survodutide bioequivalence trial alongside BI 3000202 transporter studyAug 19Weekly roundup, 2 itemsBoehringer Ingelheim
Hutchmed completes Phase 1 drug interaction study for HMPL-453 tartrate tabletsJul 13Trial updateHutchmed
AstraZeneca posts NATRON Phase III benralizumab results; registers ROSY-S anifrolumab rollover studyJul 10Weekly roundup, 9 itemsanifrolumab-fniaAstraZeneca
Janssen keeps Sporanox label approvals; J&J tapped as collaborator on new V-Wave heart failure trialJul 10Weekly roundup, 3 itemsitraconazoleJohnson & Johnson